| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.15B | — | -3.4% |
| R&D Expense | $21.0M | — | -27.6% |
| SG&A Expense | $168.0M | — | +4.3% |
| Operating Income | $123.0M | — | -13.4% |
| Pre-tax Income | $105.0M | — | +9.4% |
| Income Tax | -$4.0M | — | -140.0% |
| Net Income | $108.0M | — | +42.1% |
| EPS (Basic) | $1.50 | — | +44.2% |
| EPS (Diluted) | $1.49 | — | +44.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.01B | +2.5% | +15.9% |
| Accounts Receivable | $1.17B | -5.5% | -0.8% |
| Inventory | $824.0M | -1.4% | -7.3% |
| Current Assets | $3.27B | -2.9% | +0.3% |
| Total Assets | $5.08B | -2.2% | +0.6% |
| Current Liabilities | $1.42B | -7.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $136.0M | — | -4.2% |
| Capital Expenditures | $54.0M | — | -29.9% |
| Investing Cash Flow | -$68.0M | — | +13.9% |
| Financing Cash Flow | -$56.0M | — | +57.9% |
| Free Cash Flow | $82.0M | — | +26.2% |
| -9.5% |
| Long-term Debt | $1.45B | +2.7% | -8.2% |
| Total Liabilities | $3.33B | -5.0% | -10.0% |
| Stockholders' Equity | $1.76B | +3.5% | +30.0% |